In the process of discussing technical, scientific and/or regulatory topics during the EBF meeting often an inventory is done on best practices among member companies. These surveys held to aid the internal debate often also provide very valuable information for the bioanalytical community. For those reasons the outcomes are presented at various conferences and workshops and made available here.
On Bioanalytical Method Validation (BMV)
EBF Perspective on the New EMA Guidelines on Bioanalytical Method Validation (BMV) and input on global BMV harmonization
Presented at: The 4th Workshop on Recent Issues in Regulated Bioanalysis
22 - 23 April 2010, Montreal, Canada
EBF and EMEA concept paper on Bioanalysis and EMEA draft Guideline on Bioanalytical Method Validation: EBF's recommendations towards harmonization
Presented at: 5th Annual Bioanalysis in Clinical Research
24 - 25 February 2010, Park Plaza Victoria, London, UK
MEA concept paper on Bioanalytical Method Validation: EBF recommendations towards harmonization
Presented at: EBF 2nd Open Symposium: The Broadening Scope of Validation
2 - 4 December 2009, Hesperia Tower, Barcelona, Spain
European Pharma Companies Best Practice on Bioanalytical Method and Cross Validation for NCEs
Presented at: EBF 1st Open Conference: Burning Issues in Bioanalysis
1 - 2 December 2008, Hilton Hotel, Barcelona, Spain
On Incurred Sample Reproducibilty (ISR)
Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum
Published in: Bioanalysis 2009 1:6, 1049-1056
EBF: ISR - MIST - EMEA
Presented at: 3rd Workshop on Recent Issues in Regulated Bioanalysis
16 - 17 April 2009, Montreal, QC, Canada
Incurred Sample Reanalysis: EBF's Perspective and Experiences
Presented at: Informa Life Sciences: 4th Annual Bioanalysis in Clinical Research
11 - 12 February 2009, London, UK
Incurred Sample Reanalysis: EBF's Perspective and Experience
Presented at: EBF 1st Open Conference: Burning Issues in Bioanalysis
1 - 2 December 2008, Hilton Hotel, Barcelona, Spain
Incurred Sample Reanalysis-European Bioanalysis Forum's Perspective and Experience
Presented at: AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples - Implications of Crystal City Recommendations
7 - 8 February 2008, Hyatt Regency Crystal City, Arlington, VA, USA
EBF European Bioanalysis Forum
Presented at: BSAT Applied Pharmaceutical Analysis: Bioanalysis in Drug Development Workshop
17 September 2007, Boston, MA, USA
On Matrix Effect
Matrix Effect for MS Based Assays
Presented at: EBF/Anapharm: Crystal City III White Paper on Bioanalytical Methods
24 May 2007, Marriott Renaissance Hotel, Barcelona, Spain
On Metabolite Quantification (MIST)
Towards European Pharma Companies Best Practice on Metabolite Quantification
Presented at: 5th Annual Bioanalysis in Clinical Research
24 - 25 February 2010, Park Plaza Victoria, London, UK
Towards European Pharma Companies Best Practice on Metabolite Quantification
Presented at: EBF 2nd Open Symposium: The Broadening Scope of Validation
2 - 4 December 2009, Hesperia Tower, Barcelona, Spain
Towards European Pharma Companies Best Practice on Metabolite Quantification
Presented at: AAPS Annual Meeting 2009
8 - 12 Nov 2009, Los Angeles, CA, USA
European Pharma Companies Best Practice on Metabolite Quantification - an EBF survey on current practices and procedures
Presented at: EBF 1st Open Conference: Burning Issues in Bioanalysis
1 - 2 December 2008, Hilton Hotel, Barcelona, Spain
BMV White Paper, EBF Discussion Metabolites
Presented at: EBF/Anapharm: Crystal City III White Paper on Bioanalytical Methods
24 May 2007, Marriott Renaissance Hotel, Barcelona, Spain
On Quality
EBF Survey: Quality Systems in Macromolecule Analysis
Presented at: AAPS 2009 National Biotechnology Conference
21 - 24 June 2009, Seattle, WA, USA
Regulated or GLP Bioanalysis?
Presented at: Informa Life Sciences: 4th Annual Bioanalysis in Clinical Research
11 - 12 February 2009, London, UK
Regulated or GLP Bioanalysis?
Presented at: BSAT Applied Pharmaceutical Analysis: Bioanalysis in Drug Development Workshop
15 - 19 September 2008, Boston, MA, USA
Last update: 7 May 2010
